A cardiology journal has retracted a 2016 meta-analysis after the editors had an, ahem, change of heart about the rigor of the study. The article, “Ivabradine as adjuvant treatment for chronic heart failure,” was published in the International Journal of Cardiology, an Elsevier title. The authors, a group at the Federal University of São Paulo, […]

The post Reader complaints prompt retraction of meta-analysis of heart-failure drug appeared first on Retraction Watch.